Organizing pneumonia induced by nivolumab in a patient with metastatic melanoma

Journal of Thoracic Oncology

Volumn 11, Issue 3, 2016, Pages 432-433

  Nakashima, Kazuhisa ^a   Naito, Tateaki ^a   Omori, Shota ^a   Yoshikawa, Shusuke ^a   Endo, Masahiro ^a   Kiyohara, Yoshio ^a   Takahashi, Toshiaki ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NIVOLUMAB; PREDNISOLONE; MONOCLONAL ANTIBODY;

AGED; ANOREXIA; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; FEMALE; FEVER; HUMAN; HUMAN TISSUE; LUNG METASTASIS; MEDICAL HISTORY; METASTATIC MELANOMA; ORGANIZING PNEUMONIA; PRIORITY JOURNAL; SHORT SURVEY; TRANSBRONCHIAL BIOPSY; CHEMICALLY INDUCED; MELANOMA; PNEUMONIA;

AGED; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; MELANOMA; PNEUMONIA;

EID: 84962488967     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1016/j.jtho.2015.10.004     Document Type: Article

References (4)

1. Robert C, Long GV, Brady B, et al. Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med. 2015; 372: 320-330.
2. Brahmer J, Reckamp KL, Baas P, et al. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer. N Engl J Med. 2015; 373: 123-135.
3. Paz-Ares L, Horn L, Borghaei H, et al. Phase III, randomized Trial (CheckMate 057) of nivolumab versus docetaxel in advanced non-squamous (non-SQ) cell non-small cell lung cancer (NSCLC) [abstract]. Presented at: 51st Annual Meeting of the American Society of Clinical Oncology. May 29-June 2, 2015; Chicago, IL.
4. Nishino M, Sholl LM, Hodi FS. Anti-PD-1-related pneumonitis during cancer immunotherapy. N Engl J Med. 2015; 373: 288-290.